TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Should You Buy Valeant Pharmaceuticals Intl Inc.?

    Is Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) a falling knife you should avoid, or should you buy it with the potential…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: This Hedge Fund Manager Says Buy

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is under fire, but hedge fund manager Bill Ackman says buy.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: What Michael Pearson’s Testimony Means for the Company

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares declined by more than 7% after Michael Pearson was subpoenaed by a Senate committee.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: What Exactly Is Going On Here?

    There was another suspicious press release from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Jim Chanos and the Original Short Thesis

    Jim Chanos was short Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) before the company ran into problems.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 2 Stories That Have Flown Under the Radar

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is fighting a multi-front war.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 Lessons From Bill Ackman’s Painful Experience

    Bill Ackman has made mistakes with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) that the rest of us can learn from.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Shares Surged as Much as 17% on Monday

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares soared after the company announced Michael Pearson will be stepping down.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Is at the Mercy of its Lenders

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is trying to get its debt covenants relaxed. Penn West Petroleum Ltd. (TSX:PWT)(NYSE:PWE) has shown…

    Read more »

    The Motley Fool
    Investing

    Is Concordia Healthcare Corp. or Valeant Pharmaceuticals Intl Inc. the Better Buy?

    Investors could potentially make huge gains from Concordia Healthcare Corp. (TSX:CXR)(NYSE:CXRX) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), but which is…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Why Analysts Still Have a +$90 Price Target

    Analysts still are very bullish on Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX). Is something else going on here?

    Read more »

    The Motley Fool
    Investing

    The Epic Collapse of Valeant Pharmaceuticals Intl Inc. Continues

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have now fallen nearly 50% in the past week, prompting many investors to…

    Read more »